ARK Genomic Revolution ETF vs Direxion Daily TSLA Bull 2X Shares — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Direxion Daily TSLA Bull 2X Shares trades at $12.88. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Direxion Daily TSLA Bull 2X Shares nearer its low. Which is the better fit depends on your goals.
| ARKG | TSLL | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $23.03 |
52-Week Low | $23.09 | $10.29 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
TSLL is trading at $13.09, up 0.54% with a bearish technical signal from moving averages. Key support levels are at $12 and $11, while resistance sits at $13 and $14. The stock shows neutral oscillator readings with RSI levels around 46-50, indicating balanced momentum. Recent news highlights interest in derivative-based ETF strategies and connections to Tesla's performance.
The outlook remains cautious due to bearish technical indicators and limited fundamental data availability. Investment opportunities may exist for those speculating on Tesla-related volatility through this ETF, but risks include market volatility and dependency on underlying asset performance. The neutral sentiment from oscillators suggests waiting for clearer directional signals.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →